Annexon, Inc. Share Price
NASDAQ: ANNX | Small CapAnnexon, Inc. Stock Performance
Open $5.45 | Prev. Close $5.42 | Circuit Range N/A |
Day Range $5.26 - $5.50 | Year Range $2.03 - $7.16 | Volume 2,50,655 |
Average Traded $5.40 |
Annexon, Inc. Share Price Today
As of 11 August 2026, Annexon, Inc.'s share price is $5.40. The stock opened at $5.45, compared to its previous close of $5.42. During today's trading session, Annexon, Inc.'s share price traded between $5.26 and $5.50, with an average price of $5.38. Over the past 52 weeks, the stock has recorded a high of $7.16 and a low of $2.03. In terms of performance, Annexon, Inc.'s share price has declined by 3.57% over the last six months and is up 162.77% on a year-on-year basis.
Annexon, Inc. Share Price Chart
Annexon, Inc. Stock Fundamentals & Key Indicators
Market Cap $837.57M | PE Ratio (TTM) -4.03 | Dividend Yield N/A |
EPS (TTM) $-1.34 | Revenue (TTM) N/A | Return On Equity (TTM) -97.66% |
Profit Margin N/A | Debt to Equity 0.20 | Quarterly Earnings Growth YoY -57.71% |
Annexon, Inc. Quarterly Profit & Loss
All figures in USD
Annexon, Inc. Annual Profit & Loss
All figures in USD
About Annexon, Inc.
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company's lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Annexon, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $5.06 | $5.40 | +5.88% |
Jul 2026 | $5.86 | $5.10 | -10.76% |
Jun 2026 | $5.64 | $5.71 | +5.64% |
May 2026 | $5.93 | $5.41 | -7.84% |
Apr 2026 | $5.72 | $5.87 | +5.77% |
Mar 2026 | $5.57 | $5.55 | -0.89% |
Feb 2026 | $6.18 | $5.60 | -10.18% |
Jan 2026 | $5.09 | $6.24 | +24.45% |
Dec 2025 | $4.42 | $5.01 | +11.09% |
Nov 2025 | $3.28 | $4.51 | +42.72% |
Oct 2025 | $3.01 | $3.16 | +3.78% |
Sep 2025 | $2.05 | $3.04 | +48.18% |
ANNX Share Price FAQs
What is Annexon, Inc. share price today?
What is the 52 week high and 52 week low of Annexon, Inc. stock?
What is ANNX's market capitalisation today?
What is ANNX's net income for the last quarter?
What is the 5 year returns of ANNX?
What is the high & low stock price of ANNX today?
Can I buy ANNX shares in India?